您的位置: 首页 > 2022年1月 第52卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

脐带血冷冻前、小管复苏及大袋复苏后造血功能的比较

Comparison of hematopoietic potency of pre-freezing cord blood and post-thaw sample in attached segment and main bag

来源期刊: 广州医药 | 26-31 发布时间:2022-04-12 收稿时间:2025/11/13 18:25:58 阅读量:10
作者:
关键词:
脐带血冷冻保存附属小管CD34阳性细胞集落形成单位
cord bloodcryopreservationattached segmentCD34 positive cellscolony forming units
DOI:
10.3969/j.issn.1000-8535.2022.01.005
收稿时间:
2021-04-19 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 比较冷冻前和复苏后脐带血样本的造血功能,探讨冷冻袋附属小管是否可用于脐带血质量控制及移植供体发放前复核。方法 选取2009年3月—2021年2月在广州脐血库冻存的53份脐带血为研究对象,常规复温后,从冷冻袋和附属小管抽取样本,分为冷冻前、小管复苏和大袋复苏组。评价各组的总有核细胞(total nucleated cells,TNCs)数、细胞活率、CD34阳性细胞数量、粒-巨噬细胞集落(colony-forming units-granulocyte/macrophages, CFU-GMs)数量、祖细胞集落(colony-forming units, CFUs)数量等质量参数。结果 小管复苏后TNCs数量、细胞活率、CFU-GMs数量及CFUs数量较冷冻前均显著减少,差异有统计学意义(P<0.05),而二者的CD34阳性细胞数量差异无统计学意义(P> 0.05);大袋复苏后TNCs数量、细胞活率及CFUs数量较冷冻前各相应值比较,差异有统计学意义(P<0.05),而二者的CD34阳性细胞数量及CFU-GMs数量差异无统计学意义(P> 0.05);小管复苏后的TNCs数量、细胞活率、CD34阳性细胞活率、CFU-GMs数量及CFUs数量较大袋复苏后的相应值均减少,差异有统计学意义(P<0.05),而二者的CD34阳性细胞数量差异无统计学意义(P> 0.05)。小管复苏与大袋复苏后的各项参数存在高度相关性。结论 附属小管在一定程度上可作为脐血库质量控制和产品发放前复核的取材。
Objective To compare the hematopoietic function of cord blood before and after cryopreservation, and to explore whether sampling from the attached segment can be used for quality control of cord blood units and confirmatory testing before transplantation. Methods A total of 53 cryopreserved cord blood units from March 2009 to February 2021 in Guangzhou Cord Blood Bank were enrolled in this study. After routine thawing, samples were taken from main bag and its attached segment. They were divided into pre-freezing, post-thawing segment and post-thawing main bag groups. Total nucleated cells (TNCs), cell viability, CD34 positive cells, colony-forming units-granulocyte/macrophages(CFU-GMs)and colony-forming units (CFUs) were examined. Results The number of TNCs [(1.12±0.38)×109], cell viability [(79.11±7.71)%], the number of CFU-GMs [(5.55±4.58)×105] and the number of CFUs [(15.11±9.68)×105] were significantly decreased in samples from post-thawing attached segments compared with those pre-freezing(P<0.05), but there was no significant difference in the number of CD34 positive cells between two groups (P>0.05). The number of TNCs [(1.25±0.40)×109], cell viability [(84.75±5.89)%] and CFUs [(18.61±6.42)×105] in samples from post-thawing main bags were significantly different from those pre-freezing (P<0.05), but there were no significant differences in the number of CD34 positive cells and CFU-GMs between them (P>0.05). The number of TNCs, cell viability, CD34 positive cell viability, the numbers of CFU-GMs and CFUs were significantly decreased in post-thawing segments compared with those in main bags after thawing (P<0.05), but there was no significant difference in the number of CD34 positive cells between the two groups (P>0.05). Spearman correlation analysis showed that the parameters of samples from main bag and its attached segment were highly correlated after thawing. Conclusion Cord blood from attached segment could be quality control sample for cord blood bank and confirmatory testing before product release in some degree.
1、 BRAND A, EICHLER H, SZCZEPIORKOWSKI Z M, et al. Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise[J]. Transfusion, 2008, 48(3): 546-549. BRAND A, EICHLER H, SZCZEPIORKOWSKI Z M, et al. Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise[J]. Transfusion, 2008, 48(3): 546-549.
2、 MORGENSTERN D A, AHSAN G, BROCKLESBY M, et al. Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes[J]. Br J Haematol, 2016, 174(6):942-951. MORGENSTERN D A, AHSAN G, BROCKLESBY M, et al. Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes[J]. Br J Haematol, 2016, 174(6):942-951.
3、 GALINDO C C, VANEGAS LOZANO D M, CAMACHO RODRíGUEZ B, et al. Cord blood attached-segments are not homogeneous in post-thaw CD34+ cell viability and clonogenicity[J]. Cryobiology, 2018(82): 163-164. GALINDO C C, VANEGAS LOZANO D M, CAMACHO RODRíGUEZ B, et al. Cord blood attached-segments are not homogeneous in post-thaw CD34+ cell viability and clonogenicity[J]. Cryobiology, 2018(82): 163-164.
4、 FAIVRE L, BOUCHER H, ZERBIB R, et al. Cord blood attached segment: is this a relevant quality control to predict a good hematopoietic stem cell graft?[J]. Bone Marrow Transplant, 2017,52(9):1353-1354. FAIVRE L, BOUCHER H, ZERBIB R, et al. Cord blood attached segment: is this a relevant quality control to predict a good hematopoietic stem cell graft?[J]. Bone Marrow Transplant, 2017,52(9):1353-1354.
5、 LEE H R, SHIN S, YOON J H, et al. Attached segment has higher CD34+ cells and CFU-GM than the main bag after thawing[J]. Cell Transplant, 2015, 24(2):305-310. LEE H R, SHIN S, YOON J H, et al. Attached segment has higher CD34+ cells and CFU-GM than the main bag after thawing[J]. Cell Transplant, 2015, 24(2):305-310.
6、 RODRíGUEZ L, GARCíA J, QUEROL S. Predictive utility of the attached segment in the quality control of a cord blood graft[J]. Biol Blood Marrow Transplant, 2005, 11(4):247-251. RODRíGUEZ L, GARCíA J, QUEROL S. Predictive utility of the attached segment in the quality control of a cord blood graft[J]. Biol Blood Marrow Transplant, 2005, 11(4):247-251.
7、 van HAUTE I, LOOTENS N, de SMET S, et al. Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative?[J]. Transfusion, 2004,44(4):547-554. van HAUTE I, LOOTENS N, de SMET S, et al. Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative?[J]. Transfusion, 2004,44(4):547-554.
8、SOLVES P, PLANELLES D, MIRABET V, et al. Utility of bag segment and cryovial samples for quality control and confirmatory HLA typing in umbilical cord blood banking[J]. Clin Lab Haematol, 2004,26(6):413-418.SOLVES P, PLANELLES D, MIRABET V, et al. Utility of bag segment and cryovial samples for quality control and confirmatory HLA typing in umbilical cord blood banking[J]. Clin Lab Haematol, 2004,26(6):413-418.
9、 GOODWIN H S, GRUNZINGER L M, REGAN D M, et al. Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential[J]. Cytotherapy, 2003,5(1):80-86. GOODWIN H S, GRUNZINGER L M, REGAN D M, et al. Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential[J]. Cytotherapy, 2003,5(1):80-86.
10、 吴洁莹,廖灿,陈劲松,等. 脐血复温后细胞输入剂量对植入的预测作用分析[J].中国实验血液学杂志,2011,19(3):754-758. 吴洁莹,廖灿,陈劲松,等. 脐血复温后细胞输入剂量对植入的预测作用分析[J].中国实验血液学杂志,2011,19(3):754-758.
11、 BARKER J N, KEMPENICH J, KURTZBERG J, et al. CD34+ cell content of 126341 cord blood units in the US inventory: implications for transplantation and banking[J]. Blood Adv, 2019, 3(8):1267-1271. BARKER J N, KEMPENICH J, KURTZBERG J, et al. CD34+ cell content of 126341 cord blood units in the US inventory: implications for transplantation and banking[J]. Blood Adv, 2019, 3(8):1267-1271.
12、 HUSSEIN E, DEFOR T, WAGNER J E, et al. Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant[J]. Transfusion, 2020, 60(1):144-154. HUSSEIN E, DEFOR T, WAGNER J E, et al. Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant[J]. Transfusion, 2020, 60(1):144-154.
13、 J?RIS M, PAULSON K, FOLEY L, et al. Worldwide survey on key indicators for public cord blood banking technologies: by the World Marrow Donor Association Cord Blood Working Group[J]. Stem Cells Transl Med, 2021, 10(2):222-229. J?RIS M, PAULSON K, FOLEY L, et al. Worldwide survey on key indicators for public cord blood banking technologies: by the World Marrow Donor Association Cord Blood Working Group[J]. Stem Cells Transl Med, 2021, 10(2):222-229.
14、 Statistics Search & Match Service. Total number of donors and cord blood units[DB/OL]. https://wmda.info/about-us/media-centre/. Statistics Search & Match Service. Total number of donors and cord blood units[DB/OL]. https://wmda.info/about-us/media-centre/.
15、 YANG H, PIDGORNA A, LOUTFY M R, et al. Effects of interruptions of controlled-rate freezing on the viability of umbilical cord blood stem cells[J]. Transfusion, 2015,55(1):70-78. YANG H, PIDGORNA A, LOUTFY M R, et al. Effects of interruptions of controlled-rate freezing on the viability of umbilical cord blood stem cells[J]. Transfusion, 2015,55(1):70-78.
16、 田亚平. 细胞治疗服务标准(第9版)[J].中国研究型医院,2020,7(5):14-48. 田亚平. 细胞治疗服务标准(第9版)[J].中国研究型医院,2020,7(5):14-48.
17、 PASHA R, HOWELLA, TURNERTR, et al. Transient warming affects potency of cryopreserved cord blood units[J]. Cytotherapy, 2020,22(11):690-697. PASHA R, HOWELLA, TURNERTR, et al. Transient warming affects potency of cryopreserved cord blood units[J]. Cytotherapy, 2020,22(11):690-697.
18、 DIMAS-GONZáLEZ J, NIETO-LINARES A, MILLáN-ROCHA M, et al. Thawing methods do not affectcell viability of CD45+ and CD34+ cells, but long-term cryopreservation of umbilical cord blood units generally decreases cell viability[J]. Transfus Apher Sci,2019, 58(2): 196-200. DIMAS-GONZáLEZ J, NIETO-LINARES A, MILLáN-ROCHA M, et al. Thawing methods do not affectcell viability of CD45+ and CD34+ cells, but long-term cryopreservation of umbilical cord blood units generally decreases cell viability[J]. Transfus Apher Sci,2019, 58(2): 196-200.
19、 MOUSAVI S H, ZARRABI M, ABROUN S, et al. Umbilical cord blood quality and quantity: collection up to transplantation[J]. Asian J Transfus Sci, 2019, 13(2): 79-89. MOUSAVI S H, ZARRABI M, ABROUN S, et al. Umbilical cord blood quality and quantity: collection up to transplantation[J]. Asian J Transfus Sci, 2019, 13(2): 79-89.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录